Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Hormonal Therapy with Tamoxifen vs Aminoglutethimide and Dexamethasone vs Adrenalectomy for Metastatic Breast Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				EST-2176


2.		Phase II Mitotane plus Cortisone Acetate/Fludrocortisone and ADR for Residual, Recurrent, or Metastatic Adrenal Cortical Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 75				NCI				EST-1879

Last Modified: 7/1/1989


3.		Phase II Chemotherapy with Mitotane/CACP for Metastatic or Residual Unresectable Adrenal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8325 SEG-INT-GU-217

Last Modified: 11/19/2007


4.		Phase II Hormone Therapy with Aminoglutethimide in Patients with Relapsed Stage III/IV Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAOP-7284

Last Modified: 9/13/2006


5.		Phase II Randomized Second-Line Endocrine Therapy with AG/HC vs AG vs Low-Dose AG vs Low-Dose AG/HC vs HC in Patients with Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				postmenopausal								EORTC-10861

Last Modified: 11/1/1998


6.		Phase I Study of SUR in Patients with Advanced Cancer (Summary Last Modified 11/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				UCCRC-6274 NCI-T91-0212C, T91-0212

Last Modified: 1/1/1988


7.		Orchiectomy with or without Subsequent Adrenalectomy for Metastatic Cancer of the Male Breast and Adjuvant Therapy for Stage II Male Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				18 and over				NCI				NCI-76-C-198 NCI-MB-82, NCI-T83-1248N, T83-1248

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute